Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Bone|July 30, 2021
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOSArgia Ucci, Alfredo Cappariello, Marco Ponzetti, et al.
Cells|February 15, 2022
Hypoxia-Mimetic CoCl<sub>2</sub> Agent Enhances Pro-Angiogenic Activities in Ovine Amniotic Epithelial Cells-Derived Conditioned MediumMiriam Di Mattia, Annunziata Mauro, Simona Delle Monache, et al.
Frontiers in Molecular Biosciences|June 8, 2026
NMR metabolomics assessment of neural commitment of human dental pulp-derived stem cellsMattea Chirico, Maria Elena Pisanu, Emanuela Mari, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 15, 2019
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident CellsAlexander Loftus, Alfredo Cappariello, Christopher George, et al.
Biochemical and Biophysical Research Communications|May 3, 2025
Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the endocannabinoid systemCamilla Di Meo, Annamaria Tisi, Anna Rita Lizzi, et al.
Journal of Hematology & Oncology|January 7, 2017
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastomaGiovanni Luca Gravina, Andrea Mancini, Francesco Marampon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 25, 2018
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodelingAndrea Mancini, Alessandro Colapietro, Simona Pompili, et al.
Cells|December 28, 2019
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous GrowthClaudio Festuccia, Andrea Mancini, Giovanni Luca Gravina, et al.
Cells|October 28, 2025
Dental Pulp Stem Cell-Derived Organoids: Advancing the Development of 3D StructuresLoreto Lancia, Fanny Pulcini, Emanuela Mari, et al.
Cancers|December 31, 2025
RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. <i>Cancers</i> 2019, <i>11</i>, 1604Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Pageof 7